Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta - PubMed (original) (raw)

Review

Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta

Anita B Roberts et al. Ann N Y Acad Sci. 2003 May.

Abstract

Transforming growth factor-beta (TGF-beta), a key player in a large variety of physiological and disease processes, signals through transmembrane receptor serine/threonine kinases to activate novel signaling intermediates called Smad proteins, which then modulate transcription of target genes. We have utilized mice with a targeted deletion of Smad3, one of two homologous proteins involved in signaling from TGF-beta/activin, to investigate the function of this particular pathway in transducing such effects of TGF-beta. The dramatic results of the absence of Smad3 on parameters of healing of cutaneous wounds, such as reepithelialization and influx of inflammatory cells, as well as on fibrosis as modeled by radiation fibrosis of skin in mice, suggest that signaling flux through Smad3 is critical for chemotactic activity of TGF-beta, inhibitory effects of TGF-beta on keratinocyte proliferation and migration, and chemoattraction and elaboration of extracellular matrix by fibroblasts in fibrotic diseases. We recently identified a novel molecule, TLP for TRAP-1-like protein, which selectively interferes with Smad3 signaling, and are currently investigating whether levels of this protein might be altered in disease to change the relative flow of information from Smad2 and Smad3.

PubMed Disclaimer

Similar articles

• Is Smad3 a major player in signal transduction pathways leading to fibrogenesis?
  Roberts AB, Piek E, Böttinger EP, Ashcroft G, Mitchell JB, Flanders KC. Roberts AB, et al. Chest. 2001 Jul;120(1 Suppl):43S-47S. doi: 10.1378/chest.120.1_suppl.s43-a. Chest. 2001. PMID: 11451911
• Smad3 as a mediator of the fibrotic response.
  Flanders KC. Flanders KC. Int J Exp Pathol. 2004 Apr;85(2):47-64. doi: 10.1111/j.0959-9673.2004.00377.x. Int J Exp Pathol. 2004. PMID: 15154911 Free PMC article. Review.
• Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation.
  McKarns SC, Schwartz RH, Kaminski NE. McKarns SC, et al. J Immunol. 2004 Apr 1;172(7):4275-84. doi: 10.4049/jimmunol.172.7.4275. J Immunol. 2004. PMID: 15034041
• TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
  Felici A, Wurthner JU, Parks WT, Giam LR, Reiss M, Karpova TS, McNally JG, Roberts AB. Felici A, et al. EMBO J. 2003 Sep 1;22(17):4465-77. doi: 10.1093/emboj/cdg428. EMBO J. 2003. PMID: 12941698 Free PMC article.
• Loss of Smad3 modulates wound healing.
  Ashcroft GS, Roberts AB. Ashcroft GS, et al. Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):125-31. doi: 10.1016/s1359-6101(99)00036-2. Cytokine Growth Factor Rev. 2000. PMID: 10708960 Review.

Cited by

• Requirement of a dynein light chain in TGFbeta/Smad3 signaling.
  Jin Q, Gao G, Mulder KM. Jin Q, et al. J Cell Physiol. 2009 Dec;221(3):707-15. doi: 10.1002/jcp.21910. J Cell Physiol. 2009. PMID: 19711352 Free PMC article.
• Genome-wide transcriptional response during the development of bleomycin-induced pulmonary fibrosis in sprague-dawley rats.
  Park HJ, Yang MJ, Oh JH, Yang YS, Kwon MS, Song CW, Yoon S. Park HJ, et al. Toxicol Res. 2010 Jun;26(2):137-47. doi: 10.5487/TR.2010.26.2.137. Toxicol Res. 2010. PMID: 24278517 Free PMC article.
• TGFB1 induces fetal reprogramming and enhances intestinal regeneration.
  Chen L, Qiu X, Dupre A, Pellon-Cardenas O, Fan X, Xu X, Rout P, Walton KD, Burclaff J, Zhang R, Fang W, Ofer R, Logerfo A, Vemuri K, Bandyopadhyay S, Wang J, Barbet G, Wang Y, Gao N, Perekatt AO, Hu W, Magness ST, Spence JR, Verzi MP. Chen L, et al. Cell Stem Cell. 2023 Nov 2;30(11):1520-1537.e8. doi: 10.1016/j.stem.2023.09.015. Epub 2023 Oct 20. Cell Stem Cell. 2023. PMID: 37865088 Free PMC article.
• Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition.
  Chen X, Halberg RB, Burch RP, Dove WF. Chen X, et al. J Mol Histol. 2008 Jun;39(3):283-94. doi: 10.1007/s10735-008-9164-3. Epub 2008 Mar 8. J Mol Histol. 2008. PMID: 18327651 Free PMC article.
• Novel form of miR-29b suppresses bleomycin-induced pulmonary fibrosis.
  Yamada Y, Takanashi M, Sudo K, Ueda S, Ohno SI, Kuroda M. Yamada Y, et al. PLoS One. 2017 Feb 24;12(2):e0171957. doi: 10.1371/journal.pone.0171957. eCollection 2017. PLoS One. 2017. PMID: 28234907 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database